AHA, Others Urge HHS to Protect 340B Hospitals from Drug Companies Trying to Undermine Program

On behalf of the nation’s 340B hospitals, AHA, others urge the Department of Health and Human Services (HHS) to protect vulnerable communities from actions taken by five of the nation’s largest pharmaceutical manufacturers that undermine access to critical drugs and other health care services. We ask the HHS to use its authority to require that these and other pharmaceutical manufacturers comply with the law. This is particularly critical now as these hospitals need every resource available to care for their patients in vulnerable communities during the COVID-19 public health crisis.